Mode
Text Size
Log in / Sign up
Phase 2 N=70 Randomized Treatment

Intravenous(IV) vs. Erector Spinae Plane Blocks in Cardiac Surgery

Erector Spinae Plane Block · Pain Control · Post-Operative Pain, Chronic

Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Quantitate the Amount of Opioid Medication Required to Provide Pain Relief-Cumulative First 48 Hours — 80.2; 54.9 Morphine Milligram Equivalents

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Intravenous Administration of Lidocaine Post Cardiac Surgery (Drug); Administration of Lidocaine Post Cardiac Surgery via ESP Catheter (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Archit Sharma
Primary completion
Apr 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Quantitate the Amount of Opioid Medication Required to Provide Pain Relief-Cumulative First 48 Hours
80.2; 54.9
PRIMARY
Compare Pain Score Reported by Subject 48 Hours Postoperatively
3; 2
SECONDARY
Quantitate the Amount of Opioid Medication Required to Provide Pain Relief-0 to 24 Hours Post Surgical Intervention
49.78; 39.00
SECONDARY
Quantitate the Amount of Opioid Medication Required to Provide Pain Relief-24 to 48 Hours Post Surgical Intervention
24.5; 22.5
SECONDARY
Pain Score at 24 Hours Postoperatively
3.5; 5.0
SECONDARY
Quantify the Number of Subjects Who Had Lidocaine Plasma Levels Greater Than 5 Micrograms/Milliliter.
2; 4

Summary

Interfascial plane blocks have been developed for analgesia, among which the erector spinae plane (ESP) has gained popularity. The ESP block has been hypothesized to provide truncal analgesia by spread of local anesthetic into the paravertebral space. Recent studies have contested this idea showing unreliability in the spread of the local anesthetic into the paravertebral space.

Eligibility Criteria

Inclusion Criteria

  • Undergoing elective cardiac surgery for coronary artery bypass graft (CABG) or valve surgery via sternotomy.
  • English speaking

Exclusion Criteria

  • Emergency surgery
  • Allergy to medications (ie lidocaine)
  • BMI less than 20 or greater than 50
  • Major liver or kidney dysfunction or other pre-existing major organ dysfunction
  • Revision cardiac surgery
  • Surgery via thoracotomy
  • Off-pump coronary artery bypass
  • Narcotic dependent (Opioid intake morphine equivalents greater than 10mg/day for more than 3 months
  • Chronic pain (ie fibromyalgia)
  • Significant central nervous system or respiratory disease
  • Hematological disorders or de-ranged coagulation parameters
  • Psychiatric illness that impedes subject from providing informed consent
  • Pre-operative neurological deficits
  • Language barrier
  • Inability to provide informed consent
  • Prisoner status
  • Pregnancy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04995497). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search